MMP-7-IN-2 features a peptide-like inhibitory scaffold enabling analysis of metalloproteinase recognition and catalytic geometry. Functional groups shape binding affinity and solubility. Researchers evaluate its conformational dynamics during enzyme engagement. Uses include inhibitor profiling, mechanistic studies, and ligand optimization.
CAT No: R2491
CAS No:2848717-49-5
Synonyms/Alias:MMP-7-IN-2;CHEMBL5183142;2848717-49-5;EX-A8196;BDBM50589860;HY-153563;CS-0783940;
Mmp-7-IN-2 is a small-molecule inhibitor specifically designed to target matrix metalloproteinase-7 (MMP-7), a zinc-dependent endopeptidase implicated in various physiological and pathological processes. As a highly selective MMP-7 antagonist, this compound serves as a valuable biochemical tool for researchers investigating extracellular matrix remodeling, tissue repair, and the molecular mechanisms underlying cellular migration and invasion. The unique ability of Mmp-7-IN-2 to modulate proteolytic activity positions it as an important asset in the study of signaling pathways regulated by matrix metalloproteinases and their roles in both normal and aberrant biological contexts.
Enzyme inhibition studies: Mmp-7-IN-2 is widely employed in enzyme kinetics and inhibition assays to elucidate the specific functions of MMP-7 within complex protease networks. By selectively suppressing the catalytic activity of MMP-7, researchers can dissect its substrate specificity, regulatory mechanisms, and interactions with endogenous inhibitors. These insights are essential for mapping protease cascades involved in extracellular matrix turnover and for distinguishing the roles of individual metalloproteinases in physiological and pathological settings.
Extracellular matrix research: The compound is instrumental in studies focused on matrix biology, where it enables precise modulation of extracellular matrix degradation. Mmp-7-IN-2 allows scientists to assess the contribution of MMP-7 to the breakdown of structural proteins such as collagen and elastin, thereby advancing understanding of tissue remodeling processes. Such investigations are critical for clarifying how matrix dynamics influence cellular behavior, tissue architecture, and the regulation of developmental or disease-associated remodeling events.
Cell migration and invasion models: In cellular assays, Mmp-7-IN-2 is utilized to probe the role of MMP-7 in cell motility, invasion, and metastatic potential. By inhibiting MMP-7 activity, researchers can evaluate its impact on the ability of cells to traverse extracellular barriers, offering mechanistic insights into processes such as wound healing, morphogenesis, and invasive growth. These models are particularly valuable for delineating the molecular determinants of cell-extracellular matrix interactions and for identifying potential intervention points in abnormal migratory phenomena.
Signal transduction pathway analysis: The use of Mmp-7-IN-2 in signal transduction studies facilitates the investigation of MMP-7-mediated activation or inactivation of growth factors, cytokines, and cell surface receptors. By blocking proteolytic processing events, scientists can examine how MMP-7 modulates key signaling pathways that govern cell proliferation, differentiation, and survival. Such analyses are fundamental to unraveling the complex crosstalk between protease activity and cellular signaling networks, contributing to a more comprehensive understanding of tissue homeostasis and dysregulation.
Drug discovery and compound screening: Mmp-7-IN-2 serves as a reference inhibitor or positive control in high-throughput screening platforms aimed at identifying novel modulators of MMP-7. Its well-characterized inhibitory profile enables accurate benchmarking of candidate compounds, supporting structure-activity relationship studies and the optimization of selective metalloproteinase inhibitors. The availability of such a tool compound accelerates the early stages of drug discovery research by providing a reliable standard for evaluating specificity, potency, and off-target effects in biochemical and cellular assays.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More